Mayo Clinic
IARC Key Response Points
Abstract
Addresses three points of contention with IARC study: 1) one of the study centers was removed from the final report due to no reported cases of lung cancer among non-smokers 2)"IARC failed to adhere to its own internal guidelines for conducting epidemiological studies" and 3)the study's relative risk for ETS is too low to provide "useful guidance for health officials or policy makers." For each point, raises questions and/or provides statement to support contention.
Fields
- Notes
see 2023896970-2023896981
- Type
- Position Statement
- Q&A
- Company
- Philip Morris
- Site
- MN Depository
- Named Person
- Borelli, Thomas
- Walk, Roger
- Lee, Peter N.
- Named Organization
- IARC
- WHO
- U.S. EPA
- Region
- Vienna
- Thesaurus Term
- ETS Exposure
- Non-Smokers
- Lung Cancer
- Research Studies
- Industry Response
- Health Advocacy Groups
- Keyword
- IARC Multinational Study on ETS and Lung Cancer
No images found for document.